WHO, EU, EMA agreement to improve quality and safety of medicines

Xin Weisheng

Home > News > INDUSTRY NEWS >

09 Sep 2015
WHO, EU, EMA agreement to improve quality and safety of medicines
With globalized markets and increasing cross-border trade, protecting patients from unsafe, substandard and dangerous medical products requires global action based on information sharing and collaboration between many actors involved in medicines oversight.

WHO, the European Commission and the European Medicines Agency (EMA) have signed a confidentiality agreement to start sharing information on the safety, quality and efficacy of medicines already authorised or under review in the European Union (EU), or prequalified or under review by WHO.

The arrangement strengthens an already solid collaboration between the agencies in the context of several international harmonization and convergence initiatives and bilateral arrangements. Under the new agreement, EMA and WHO can share information such as drug safety data on products already on the market, particularly related to adverse drug reactions and other safety concerns; information on applications for scientific advice, marketing authorisation or post-authorisation activities of significant public health interest; and data related to inspections of manufacturing facilities and clinical research activities.

The cooperation will also make it easier and quicker to take action to protect public health when defective medicines threats emerge.

The WHO-EMA agreement is expected to avoid duplication of quality assessments, thus accelerating patients’ access to quality treatment, and improve the authorisation and safety of medicines by involving the best expertise from both sides.

(Source: WHO)
  • wechat
Recent Posts
  • Biosphere zaps germs with UV light to make biomanufacturing cheaper
    09 Jan 2025
    Biosphere zaps germs with UV light to make biomanufacturing cheaper
    Find out more
  • China's API Dominance Reshapes Global Pharmaceutical Supply Chains
    04 Dec 2024
    China's API Dominance Reshapes Global Pharmaceutical Supply Chains
    Find out more
  • From mundane to marvelous: The current and future uses of AI
    13 Nov 2024
    From mundane to marvelous: The current and future uses of AI
    Find out more

WANT TO KNOW MORE ABOUT HOW OUR

SOLUTIONS CAN HELP YOU?

Cookies
Our site uses cookies. We’d also like to set optional cookies to give you the best experience and porvide you relevant advertising. You can choose to manage your preferences or accept all cookies. You can also read our Privacy Policy and Cookie Policy for more information.